number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide GLP-1 Market Size, Share GLP-1 Medications for Weight Loss:

The overall discontinuation rate was 4.3% to 7.1% (Jastreboff et al., NEJM 2022)

This level of weight loss has not been replicated with other glucose-lowering interventions or lifestyle changes alone

Overall, proper oral administration may support systemic and gut-specific repair effectively, while localized injections or intravenous therapy is more suitable for targeted musculoskeletal issues

Modern GLP-1 drugs are designed to mimic the activity of the natural GLP-1 hormone, activating the GLP-1 receptor for longer periods than the bodys own hormone typically lasts

As a result, medicinal development shifted towards reversible, non-covalent drugs and largely avoided covalent mechanisms for decades

Backed by purity, precision, and performance for your research needs